Compare VSTM & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSTM | ERII |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 437.1M |
| IPO Year | 2011 | 2008 |
| Metric | VSTM | ERII |
|---|---|---|
| Price | $6.68 | $7.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $16.50 | ★ $17.07 |
| AVG Volume (30 Days) | ★ 2.0M | 963.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | 5.00 |
| EPS | N/A | ★ N/A |
| Revenue | $30,914,000.00 | ★ $134,987,000.00 |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | $20.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $3.43 | $7.51 |
| 52 Week High | $11.25 | $18.31 |
| Indicator | VSTM | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 57.05 | 38.43 |
| Support Level | $6.68 | $7.68 |
| Resistance Level | $7.05 | $9.18 |
| Average True Range (ATR) | 0.48 | 0.40 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 50.44 | 9.84 |
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.